Skip to content

Himanshu Khandelia

4 papers in the library · 42 citations · publishing 2022-2025

Papers

Sort Most recent Most cited

Molecular insights into the modulation of the 5HT2A receptor by serotonin, psilocin, and the G protein subunit Gqα.

FEBS Letters March 1, 2025 Niklas Viohl, Ali Asghar Hakami Zanjani, Himanshu Khandelia 7 citations

5HT2AR is a G-protein-coupled receptor that drives many neuronal functions and is a target for psychedelic drugs. Understanding ligand interactions and conformational transitions is essential for developing effective pharmaceuticals, but mechanistic details of 5HT2AR activation remain poorly understood. We utilized all-atom molecular dynamics simulations and free-energy calculations to...

The molecular basis of the antidepressant action of the magic mushroom extract, psilocin.

Biochimica et biophysica acta. Proteins and proteomics July 1, 2023 Ali Asghar Hakami Zanjani, Teresa Quynh Tram Nguyen, Luise Jacobsen et al. 6 citations

Magic mushrooms, and their extract psilocybin, are well-known for their psychedelic properties and recreational use. Psilocin, the bio-active form of psilocybin, can potentially treat various psychiatric diseases. Psilocin putatively exerts its psychedelic effect as an agonist to the serotonin 2A receptor (5-HT2AR), which is also the receptor for the neurological hormone serotonin. The two key...

Interaction of psychedelic tryptamine derivatives with a lipid bilayer

Chemistry and Physics of Lipids January 7, 2023 Fateme Zohairi, Himanshu Khandelia, Ali Asghar Hakami Zanjani 20 citations

Naturally occurring psychedelics have been used for a long time as remedies or in religious ceremonies and recreational activities. Recent studies have proven the therapeutic potential of some psychedelic compounds to safely treat a wide range of diseases such as anxiety, depression, migraine, and addiction. It is hypothesized that psychedelic compounds like tryptamines can exert their effects...

Magic mushroom extracts in lipid membranes

Biochimica et Biophysica Acta (BBA) - Biomembranes May 10, 2022 Teresa Quynh Tram Nguyen, Frederik W. Lund, Ali Asghar Hakami Zanjani et al. 9 citations

The active hallucinogen of magic mushrooms, psilocin, is being repurposed to treat nicotine addiction and treatment-resistant depression. Psilocin belongs to the tryptamine class of psychedelic compounds which include the hormone serotonin. It is believed that psilocin exerts its effect by binding to the serotonin 5-HT2A receptor. However, recent in-vivo evidence suggests that psilocin may...